对肝细胞癌早期恶性转变的分子洞察力
bioRxiv : the preprint server for biology
|May 5, 2025
概括
这项研究揭示了早期肝癌发展中的关键分子变化,表明染色体不稳定性和免疫逃避是至关重要的. 这些发现表明,在肝细胞癌 (HCC) 早期免疫疗法干预的新途径.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 癌症基因组学 癌症基因组学
- 免疫学 免疫学 免疫学
背景情况:
- 在癌症发生过程中,从前恶性病变转变为恶性病变的理解很少,特别是在肝细胞癌 (HCC) 中.
- 在肝癌发展中采样过渡性病变存在重大挑战.
研究的目的:
- 为了全面描述非常早期肝细胞癌 (veHCCs) 的基因组和免疫学景观.
- 阐明 HCC 发病和进展背后的分子机制.
主要方法:
- 对21个VeHCC和17个易患癌症的发育不良结节 (DN) 的基因组分析.
- 瘤微环境的免疫学分析.
- 对拷贝数变化 (CNA) 和单核酸变异 (SNV) 的分析.
主要成果:
- 在82%的易患癌症的DNA中发现了TERT变化,这表明它具有诱导作用.
- 观察到CNA负担显著增加,而不是SNVs,突出显示染色体不稳定性.
- veHCCs表现出免疫不活性或早期免疫逃避,挑战慢性炎症范式.
- 提出了两个进展模型:CNA主导和早期免疫逃避.
结论:
- 已经确定了HCC启动中的新分子范式.
- 染色体不稳定和免疫逃避在早期肝癌中至关重要.
- 早期免疫疗法干预对HCC具有治疗潜力.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.7K
08:40A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
6.1K
相关概念视频
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
